N.F.U. Mutual Unit Managers Ltd’s BioMarin Pharmaceuticals BMRN Stock Holding History

N.F.U. Mutual Unit Managers Ltd’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$280K	Buy	+4,670	New	+$294K	0.05%	186

Other funds holding BMRN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

N.F.U. Mutual Unit Managers Ltd's BMRN Position: Q3 2026 in Review

N.F.U. Mutual Unit Managers Ltd opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 4,670 shares worth $280K. The stake represents 0.05% of the portfolio and ranks #186 among its holdings.

434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

N.F.U. Mutual Unit Managers Ltd held 4,670 shares of BioMarin Pharmaceuticals worth $280K as of Q3 2026.
BioMarin Pharmaceuticals was a new N.F.U. Mutual Unit Managers Ltd position in Q3 2026.
BioMarin Pharmaceuticals made up 0.05% of N.F.U. Mutual Unit Managers Ltd's portfolio in Q3 2026, its #186 holding.
434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on N.F.U. Mutual Unit Managers Ltd's 13F filing for Q3 2026, filed 12 Nov 2026.